Stuart W. Peltz's most recent trade in PTC Therapeutics Inc was a trade of 2,320 Common Stock done at an average price of $45.6 . Disclosure was reported to the exchange on Jan. 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 2,320 | 166,962 (0%) | 0% | 45.6 | 105,857 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 301 | 54,903 (0%) | 0% | 45.6 | 13,734 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 284 | 55,204 (0%) | 0% | 47.5 | 13,476 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 1,228 | 170,471 (0%) | 0% | 42.9 | 52,722 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 1,189 | 169,282 (0%) | 0% | 44.4 | 52,744 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 571 | 55,980 (0%) | 0% | 42.9 | 24,515 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 492 | 55,488 (0%) | 0% | 44.4 | 21,825 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 1,786 | 171,699 (0%) | 0% | 41.7 | 74,398 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 279 | 56,551 (0%) | 0% | 41.7 | 11,622 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 132,500 | 132,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 53,000 | 173,485 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,000 | 56,830 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.83 per share. | 07 Jun 2022 | 407 | 38,239 (0%) | 0% | 26.8 | 10,919 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.28 per share. | 14 Apr 2022 | 82 | 38,646 (0%) | 0% | 45.3 | 3,713 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 1,961 | 120,485 (0%) | 0% | 40.0 | 78,444 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 282 | 38,728 (0%) | 0% | 40.0 | 11,281 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.32 per share. | 25 Jan 2022 | 330 | 39,010 (0%) | 0% | 39.3 | 12,974 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 44,000 | 122,446 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 16,800 | 39,340 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 1,869 | 78,446 (0%) | 0% | 38.5 | 72,003 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 294 | 22,540 (0%) | 0% | 38.5 | 11,326 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.16 per share. | 04 Jan 2022 | 378 | 22,834 (0%) | 0% | 41.2 | 15,559 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 36,400 | 36,400 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 6,240 | 22,721 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2021 | 1,400 | 16,481 (0%) | 0% | 0 | Common Stock |